Bellevue Asset Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.5K | Hold |
482
| – | – | 0.01% | 242 |
|
|
2025
Q1 | $18.7K | Hold |
482
| – | – | 0.01% | 237 |
|
|
2024
Q4 | $16.3K | Hold |
482
| – | – | 0.01% | 250 |
|
|
2024
Q3 | $19.7K | Hold |
482
| – | – | 0.01% | 229 |
|
|
2024
Q2 | $18.6K | Sell |
482
-450
| -48% | -$17.3K | 0.01% | 229 |
|
|
2024
Q1 | $40K | Hold |
932
| – | – | 0.02% | 172 |
|
|
2023
Q4 | $34.5K | Hold |
932
| – | – | 0.03% | 181 |
|
|
2023
Q3 | $33.8K | Hold |
932
| – | – | 0.02% | 174 |
|
|
2023
Q2 | $33.2K | Hold |
932
| – | – | 0.02% | 182 |
|
|
2023
Q1 | $33.2K | Hold |
932
| – | – | 0.02% | 182 |
|
|
2022
Q4 | $32.6K | Hold |
932
| – | – | 0.03% | 187 |
|
|
2022
Q3 | $28K | Hold |
932
| – | – | 0.02% | 199 |
|
|
2022
Q2 | $51K | Hold |
932
| – | – | 0.04% | 157 |
|
|
2022
Q1 | $51K | Hold |
932
| – | – | 0.03% | 170 |
|
|
2021
Q4 | $51K | Hold |
932
| – | – | 0.03% | 175 |
|
|
2021
Q3 | $45K | Hold |
932
| – | – | 0.03% | 183 |
|
|
2021
Q2 | $46K | Sell |
932
-160
| -15% | -$7.9K | 0.03% | 182 |
|
|
2021
Q1 | $49K | Hold |
1,092
| – | – | 0.03% | 175 |
|
|
2020
Q4 | $53K | Sell |
1,092
-95
| -8% | -$4.61K | 0.03% | 163 |
|
|
2020
Q3 | $56K | Hold |
1,187
| – | – | 0.04% | 150 |
|
|
2020
Q2 | $61K | Hold |
1,187
| – | – | 0.06% | 142 |
|
|
2020
Q1 | $63K | Buy |
1,187
+95
| +9% | +$5.04K | 0.07% | 140 |
|
|
2019
Q4 | $64K | Buy |
+1,092
| New | +$64K | 0.05% | 127 |
|